Podcast: This Week in Managed Care—New Drug Pricing Probe and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a new investigation into drug prices; FDA Commissioner Scott Gottlieb, MD, provided updates on how the government shutdown is impacting FDA work; research found comorbidities impede clinical trial participation for patients with cancer.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Listen above or through one of these podcast services:

Biologics, Diabetes, Cancer Drugs on House Oversight Probe List

HHS Medicare Drug Shift Plan Could Reduce Costs Overall but Raise Them for Some, Researchers Say

What We're Reading: FDA Resumes Some Inspections; Walmart Leaves CVS' PBM Networks; Flu Season

Comorbidities Impede Clinical Trial Participation Among Patients With Cancer

Understanding What Drives Health Information Exchange Use During Postacute Care Transitions

The American Journal of Managed Care®—January 2019, Health IT Issue

Read more about the stories in this podcast: